Business
Axcan Pharma to present at CIBC World Markets Biotechnology & Specialty Pharmaceuticals Conference
Axcan Pharma to present at CIBC World Markets Biotechnology & Specialty Pharmaceuticals Conference.
About this update from Trailbreaker Resources Ltd
[{"type":"text","content":"\n\n\n\n\nTSX SYMBOL (Toronto Stock Exchange): AXP\nNASDAQ SYMBOL (NASDAQ National Market): AXCA\n\nMONT SAINT-HILAIRE, QC, March 28 /CNW Telbec/ - Axcan Pharma Inc.\n(\"Axcan\" or the \"Company\") today announced that on Tuesday, April 4th, 2006,\nPresident and Chief Executive Officer, Frank A.G.M. Verwiel, M.D., will\npresent an overview of the Company at the CIBC World Markets Biotechnology &\nSpecialty Pharmaceuticals Conference to be held in New York, NY. This\npresentation will take place at 10:00 a.m. local time.\nA webcast of Axcan's presentation will also be accessible via the\nCompany's website at www.axcan.com.\n\nAxcan is a leading specialty pharmaceutical company involved in the field\nof gastroenterology. The Company markets a broad line of prescription products\nsold for the treatment of symptoms in a number of gastrointestinal diseases\nand disorders such as inflammatory bowel disease, irritable bowel syndrome,\ncholestatic liver diseases and complications related to cystic fibrosis.\nAxcan's products are marketed by its own sales force in North America and\nEurope. Its common shares are listed on the Toronto Stock Exchange under the\nsymbol \"AXP\" and on the NASDAQ National Market under the symbol \"AXCA\".\n\n\n","length":1304,"tagName":"div"}]